文献速递免疫规划卫生政策与健康促进

在美洲建设疫苗不良事件主动监测能力:一个基于医院的多国网络

Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network.
PubMed 文献 · Vaccine · 2017-08-10

该研究在美洲7个国家15个哨点站点建立基于医院的疫苗安全主动监测系统,评估麻疹-腮腺炎-风疹疫苗与免疫性血小板减少性紫癜(ITP)及无菌性脑膜炎的关联,区域网络向全球研究贡献了63例确诊ITP和16例确诊无菌性脑膜炎合格病例,分别占全球总病例的33%和19%。

要点

  • 在美洲7国15个哨点建立基于医院的疫苗不良事件主动监测网络。
  • 评估麻腮风疫苗与ITP及无菌性脑膜炎的关联。
  • 网络贡献63例ITP和16例无菌性脑膜炎病例,分别占全球33%和19%。

核心结论

  • 该基于医院的多国主动监测网络在美洲7国15个哨点成功实施了概念验证研究,评估麻腮风疫苗与ITP及无菌性脑膜炎的关联。
  • 为保障长期可持续性并用于调查中低收入国家新疫苗引入后的不良事件,该网络需增加站点并整合入国家卫生系统。

研究设计与样本

  • 在美洲地区7个国家的15个哨点站点开发并实施了一项概念验证研究,评估国际协作的基于医院疫苗安全主动监测系统的可行性。
  • 研究在WHO全球疫苗安全倡议框架下开展,评估麻腮风疫苗与ITP及无菌性脑膜炎两种公认不良事件的关联。

主要发现

  • 区域网络向全球研究贡献了63例确诊ITP合格病例和16例确诊无菌性脑膜炎合格病例。
  • 区域网络贡献的ITP病例占全球总病例的33%,无菌性脑膜炎病例占全球总病例的19%。

局限性

  • 为保障长期可持续性并用于调查中低收入国家新疫苗引入后的不良事件,该网络需增加站点并整合入国家卫生系统。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

New vaccines designed to prevent diseases endemic in low and middle-income countries are being introduced without prior utilization in countries with robust vaccine pharmacovigilance systems. Our aim was to build capacity for active surveillance of vaccine adverse events in the Americas. We describe the implementation of a proof-of-concept study for the feasibility of an international collaborative hospital-based active surveillance system for vaccine safety. The study was developed and implemented in 15 sentinel sites located in seven countries of the region of the Americas, under the umbrella of the World Health Organization (WHO) Global Vaccine Safety Initiative. The study evaluated the associations between measles-mumps-rubella vaccines and two well-recognized adverse events: Immune thrombocytopenic purpura (ITP) and aseptic meningitis. The regional network contributed 63 confirmed ITP and 16 confirmed aseptic meningitis eligible cases to the global study, representing, respectively, 33% and 19% of the total cases. To ensure long-term sustainability and usefulness to investigate adverse events following new vaccine introductions in low and middle-income countries, the network needs to be strengthened with additional sites and integrated into national health systems.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bravo-Alcántara P, Pérez-Vilar S, Molina-León HF, et al. Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network. Vaccine. 2017. PMID: 28803714. doi:10.1016/j.vaccine.2017.04.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。